616.234.5000
Learn More
The olfactory bulb as the entry site for prion-like propagation in
neurodegenerative diseases
Learn More

Diabetes drug slows experimental Parkinson’s disease progression,
human trials to begin next year

 

TRANSLATIONAL PARKINSON’S DISEASE RESEARCH

Patrik Brundin Laboratory
Research in Patrik Brundin’s laboratory focuses on pathogenetic mechanisms and pharmacological treatment in cell and animal models of Parkinson’s disease. The group’s mission is to understand neurodegenerative diseases and develop new therapies that are of benefit
to patients and their caregivers.

Learn More

Facebook